Ezrin immunoreactivity reveals specific astrocyte activation in cerebral HIV

Journal of Neuropathology and Experimental Neurology

Volumn 65, Issue 1, 2006, Pages 87-96

  Geiger, Kathrin D ^a,b,d   Stoldt, Peter ^a   Schlote, Wolfgang ^a   Derouiche, Amin ^b,c  

^a GOETHE UNIVERSITY   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d Institute for Pathology   (Germany)

Author keywords

AIDS; Apoptosis; ERM proteins; HIV; HIV encephalopathy

Indexed keywords

ACTIN BINDING PROTEIN; EZRIN; FERRITIN; GLIAL FIBRILLARY ACIDIC PROTEIN; HLA DR ANTIGEN; CYTOSKELETON PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AIDS PATIENT; APOPTOSIS; ARTICLE; ASTROCYTE; AUTOPSY; BRAIN INFECTION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; NICK END LABELING; PRIORITY JOURNAL; RECEPTOR UPREGULATION; TISSUE SECTION; CADAVER; CELL COUNT; CLASSIFICATION; COMPARATIVE STUDY; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; MIDDLE AGED; NERVE CELL; PATHOLOGY; PHYSIOLOGY; TIME;

AIDS DEMENTIA COMPLEX; APOPTOSIS; ASTROCYTES; CELL COUNT; CYTOSKELETAL PROTEINS; FEMALE; FERRITINS; GLIAL FIBRILLARY ACIDIC PROTEIN; HIV INFECTIONS; HLA-DR ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MIDDLE AGED; NEURONS; POSTMORTEM CHANGES; TIME FACTORS;

EID: 33644928777     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jnen.0000195943.32786.39     Document Type: Article

References (81)

1. Gould KL, Bretscher A, Esch FS, Hunter T. cDNA cloning and sequencing of the protein-tyrosine kinase substrate, ezrin, reveals homology to the band 4.1. EMBO J 1989;8:4133-42
2. Bretscher A. Rapid phosphorylation and reorganization of ezrin and spectrin accompany morphological changes induced in A-431 cells by epidermal growth factor. J Cell Biol 1989;108:921-30
3. Bretscher A, Reczek D, Berryman M. Ezrin: A protein requiring conformational activation to link microfilaments to the plasma membrane in the assembly of cell surface structures. J Cell Sci 1997;110:3011-18
4. Tsukita S, Hieda Y, Tsukita S. A new 82 kD- barbed end-capping protein localized in the cell-to-cell adherens junction: Purification and characterization. J Cell Biol 1989;108:2369-82
5. Vaheri A, Carpén O, Heiska L, et al. The ezrin protein family: Membrane-cytoskeleton interactions and disease associations. Curr Cell Biol 1997;9:659-66
6. Takeuchi K, Sato N, Kasahara H, et al. Perturbation of cell adhesion and microvilli formation by antisense oligonucleotides to ERM family members. J Cell Biol 1994;125:1371-84
7. Nakamura H, Ozawa H. Immunolocalization of CD 44 and the ezrin-radixin-moesin (ERM) family in the stratum intermedium and papillary layer of the mouse enamel organ. J Histochem Cytochem 1997;45:1481-92
8. Helander TS, Carpén O, Turunen O, Kovanen PE, Vaheri A, Timonen T. ICAM-2, redistributed by ezrin as a target for killer cells. Nature 1996;382:265-68
9. Tsukita S, Oishi K, Sato N, Sagara J, Kawai A, Tsukita S. ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J Cell Biol 1994;126:391-401
10. Böhling T, Turunen O, Jääskeläinen J, et al. Ezrin expression in stromal cells of capillary hemangioblastoma. An immunohistochemical survey of brain tumors. Am J Pathol 1996;148:367-73
11. Derouiche A, Frotscher M. Peripheral astrocyte processes: Monitoring by selective immunostaining for the actin-binding ERM proteins. Glia 2001;36:330-41
12. Geiger KD, Stoldt P, Schlote W, Derouiche A. Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas. Am J Pathol 2000;157:1785-93
13. Gronholm M, Teesalu T, Tyynela J, et al. Characterization of the NF2 protein merlin and the ERM protein ezrin in human, rat, and mouse central nervous system. Mol Cell Neurosci 2005;28:683-93
14. Roumier A, Olivo-Marin JC, Arpin M, et al. The membrane-microfilament linker ezrin is involved in the formation of the immunological synapse and in T cell activation. Immunity 2001;15:715-28
15. Serrador JM, Vicente-Manzanares M, Calvo J, et al. A novel serine-rich motif in the intercellular adhesion molecule 3 is critical for its ERM-directed subcellular targeting. J Biol Chem 2002;277:10400-10409
16. Parlato S, Giammarioli AM, Logozzi M, et al. CD95 (APO-1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: A novel regulatory mechanism of the CD 95 apoptotic pathway. EMBO J 2000;19:5123-34
17. Lara-Pezzi E, Serrador JM, Montoya MC, et al. The hepatitis B virus X protein (HBx) induces a migratory phenotype in a CD44-dependent manner: Possible role of HBx in invasion and metastasis. Hepatology 2001;33:1270-81
18. Zohar R, Suzuki N, Suzuki K, et al. Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration. J Cell Physiol 2000;184:118-30
19. Benn T, Halfpenny C, Scolding N. Glial cells as targets for cytotoxic immune mediators. Glia 2001;36:200-11
20. Dong Y, Benveniste EN. Immune function of astrocytes. Glia 2001;36:180-90
21. Pender MP, Rist MJ. Apoptosis of inflammator cells in immune control of the nervous system: Role of glia. Glia 2001;36:137-44
22. Berry M, Butt AM. Structure and function of glia in the central nervous system. In: Graham DI, Lantos PL, eds. Greenfield's Neuropathology. London: Arnold Publishers, 1997:63-84
23. Kreutzberg GW, Blakemore WF, Graeber MB. Cellular pathology of the central nervous system. In: Graham DI, Lantos PL, eds. Greenfield's Neuropathology. London: Arnold Publishers, 1997: 85-156
24. Tsukita S, Yonemura S, Tsukita S. ERM (ezrin/radixin/moesin) family: From cytoskeleton to signal transduction. Curr Opin Cell Biol 1997;9:70-75
25. Sabri F, Titanji K, De Milito A, Chiodi F. Astrocyte activation and apoptosis: Their roles in the neuropathology of HIV infection. Brain Pathol 2003;13:84-89
26. Nath A, Hartloper V, Furer M, Fowke KR. Infection of human fetal astrocytes with HIV-1 : Viral tropism and the role of cell to cell contact in viral transmission. J Neuropathol Exp Neurol 1995;54:320-30
27. Eggers C. [HIV-1 associated encephalopathy and myelopathy.] Nervenarzt 2000;71:677-84
28. Messam CA, Major EO. Stages of restricted HIV-1 infection in astrocyte cultures derived from human fetal brain tissue. J Neurovirol 2000;2000:S90-94
29. Mossakowski MJ, Zelman IB. Neuropathological syndromes in the course of full-blown acquired immune deficiency syndrome (AIDS) in adults in Poland (1987-1995). Folia Neuropathol 1997;35:133-43
30. Jellinger KA, Setinek U, Drlicek M, Bohm G, Steurer A, Lintner F. Neuropathology and general autopsy findings in AIDS during the last 15 years. Acta Neuropathol 2000;100:213-20
31. Gray F, Adle-Biassette H, Chretien F, Lorin de la Grandmaison G, Force G, Keohane C. Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments. Clin Neuropathol 2001;20:146-55
32. Bell JE. The neuropathology of adult HIV infection. Rev Neurol 1998;154:816-29
33. Neuenburg JK, Brodt HR, Herndier BG, Bickel M, Bacchetti P. HIV-related neuropathology, 1985-1999: Rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2002;31:171-77
34. Geiger KD, Bloom FE, Sarvetnick NE. Methods for the detection of apoptosis in the CNS. In: Poirier J, ed. Apoptosis Techniques and Protocols, vol 29. Totowa, NJ: Humana Press, 1997: 217-35
35. Borras D, Pumarola M, Ferrer I. Neuronal nuclear DNA fragmentation in the aged canine brain: Apoptosis or nuclear DNA fragility? Acta Neuropathol 2000;99:402-8
36. Davison FD, Groves M, Scaravilli F. The effects of formalin fixation on the detection of apoptosis in human brain by in situ end-labelling of DNA. Histochem J 1995;27:983-88
37. Schallock K, Schulz-Schaeffer WJ, Giese A, Kretzschmar HA. Postmortem delay and temperature conditions affect the in situ end-labeling (ISEL) assay in brain tissue of mice. Clin Neuropathol 1997;16:133-36
38. Whiteside G, Cougnon N, Hunt SP, Munglani R. An improved method for detection of apoptosis in tissue sections and cell culture using the TUNEL technique combined with Hoechst stain. Brain Res Protocols 1998;2:160-64
39. Brettle RP, Gore SM, Bird AG, McNeil AJ. Clinical and epidemiological implications of the Centers for Disease Control/World Health Organization reclassification of AIDS cases. AIDS 1993;7:531-39
40. Centers for Disease Control and Prevention. 1992 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1993;41:961-62
41. Gallant JE, Somani J, Chaison RE, et al. Diagnostic accuracy of three clinical case definitions for advanced HIV disease. AIDS 1992;6:295-99
42. Mc Cain NL, Lyon DE, Higginson R, Settle J. Revision of HIV center medical staging scale. J Assoc Nurses AIDS Care 1998;9:19-23
43. Schlote W. HIV encephalopathy. Verhandl Dt Gesellsch Pathol 1991;17:51-60
44. Neuen-Jacob E, Prestien K, Jablonowski H, Freund HJ. A pathologically distinct new form of HIV associated encephalopathy. J Neurol Sci 1994;121:215-21
45. Dickson DW. Microglia as reservoirs and perpetrators of HIV CNS disease. In: Gendelman H, Lipton SA, Epstein L, Swindells S, eds. The Neurology of AIDS. New York: ITP, 1998: 97-116
46. Navia B, Price RW. Clinical and biologic features of the AIDS dementia complex. In: Gendelman H, Lipton SA, Epstein L, Swindells S, eds. The Neurology of AIDS. New York: ITP, 1998: 229-40
47. Budka H. Human immunodeficiency virus (HIV)-induced disease of the central nervous system: Pathology and implications for pathogenesis. Acta Neuropathol 1989;77:225-36
48. Cinque P, Vago L, Dahl H, Brytting M, et al. Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patients. AIDS 1996;10:951-58
49. Yao X, Cheng L, Forte JG. Biochemical characterization of ezrin-actin interaction. J Biol Chem 1996;271:7224-29
50. Pawlik K. The maximal contingency coefficient in the case of nonquadratic contingency tables. Metrika 1959;2:123-26
51. Sachs L. Anwendung von statistischen Methoden (Application of statistical methods). In: Angewandte Statistik (Application of Statistics). Berlin, Heidelberg, New York: Springer, 1992: 476
52. Bell JE. An update on the neuropathology of HIV in the HAART era. Histopathology 2004;45:549-59
53. Levy J. Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 1993;57:183-89
54. Schielke E. HIV encephalopathy - Clinical aspects, neuropathology and pathogenesis. Nervenarzt 1993;64:83-90
55. Simpson DM. Human immunodeficiency virus-associated dementia: Review of pathogenesis, prophylaxis, and treatment studies of zidovudine therapy. Clin Infect Dis 1999;29:19-34
56. Cornford ME, Holden JK, Boyd MC, Berry K, Vinters HV. Neuropathology of the acquired immune deficiency syndrome (AIDS): Report of 39 autopsies from Vancouver, British Columbia. Can J Neurol Sci 1992;19:442-52
57. Funata N, Maeda Y, Koike M. Neuropathology of the central nervous system in acquired immune deficiency syndrome (AIDS) in Japan. Acta Pathol Jpn 1991;41:206-11
58. van Hemel K. Hypothesis: Multinucleated giant cells in AIDS neuropathology. Rev Neurol 1989;145:802-5
59. Kaul M, Garden GA, Lipton SA. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001;410:988-94
60. Sharer LR. Pathology of HIV-1 infection of the central nervous system: A review. J Neuropathol Exp Neurol 1992;51:3-11
61. Brodie C, Weizman N, Katzoff A, Lustig S, Kobiler D. Astrocyte activation by Sindbis virus: Expression of GFAP, cytokines, and adhesion molecules. Glia 1997;19:275-85
62. Smits HA, Boven LA, Pereira CF, Verhoef J, Nottet HS. Role of macrophage activation in the pathogenesis of Alzheimer's disease and human immunodeficiency. Eur J Clin Invest 2000;30:469-70
63. Benveniste EN. Inflammatory cytokines within the central nervous system: Sources, function, and mechanism of action. Am J Physiol 1992;263:C1-16
64. Bezzi P, Domercq M, Brambilla L, et al. CXCR4-activated astrocyte glutamate release via TNF alpha: Amplification by microglia triggers neurotoxicity. Nat Neurosci 2001;4:702-10
65. Gray F, Adle-Biassette H, Brion F, et al. Neuronal apoptosis in human immunodeficiency virus infection. J Neurovirol 2000;6(suppl1):S38-43
66. Fazakerley JK, Garden GA, Lipton SA. Programmed cell death in virus infections of the nervous system. Curr Top Microbiol Immunol 2001;253:95-119
67. Gabuzda D, Wang J. Chemokine receptors and mechanisms of cell death in HIV neuropathogenesis. J Neurovirol 2000;6(suppl1):S24-32
68. Estaquier J, Idziorek T, De Bels F, et al. Programmed cell death and AIDS: Significance of T cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc Natl Acad Sci U S A 1994;91:9431-35
69. Thompson KA, McArthur JC, Wesselingh SL. Correlation between neurological progression and astrocyte apoptosis in HIV-associated dementia. Ann Neurol 2001;49:745-52
70. Ott DE, Coren LV, Kane BP, et al. Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. J Virol 1996;70:7734-43
71. Hecker C, Weise C, Schneider-Schaulies J, Holmes HC, ter Meulen V. Specific binding of HIV-1 envelope protein gp 120 to the structural membrane proteins ezrin and moesin. Virus Res 1997;49:215-23
72. Birgbauer E, Dinsmore JH, Winckler B, Lander AD, Solomon F. Association of ezrin isoforms with the neuronal cytoskeleton. J Neurosci Res 1991;30:232-41
73. Masliah E, Ge N, Achim CL, Hansen LA, Wiley CA. Selective neuronal vulnerability in HIV-encephalitis. J Neuropathol Exp Neurol 1992;51:585-93
74. Corasaniti MT, Bagetta G, Rotiroti D, Nistico G. The HIV envelope protein gp 120 in the nervous system: Interactions with nitric oxide, interleukin-1 beta and nerve growth factor signalling, with pathological implications in vivo and in vitro. Biochem Pharmacol 1998;56:153-56
75. Kondo T, Takeuchi K, Doi Y, Yonemura S, Nagata S, Tsukita S. ERM (ezrin/radixin/moesin)-based molecular mechanism of microvillar break-down at an early stage of apoptosis. J Cell Biol 1997;139:749-58
76. Luciani F, Matarrese P, Giammarioli AM, et al. CD95/phosphorylated ezrin association underlies HIV-1 GP120/IL-2-induced susceptibility to CD95 (APO-1/Fas)-mediated apoptosis of human resting CD4(+) Lymphocytes. Cell Death Differ 2004;11:574-82
77. Marhaba R, Bourouba M, Zoller M. CD44v7 interferes with activation-induced cell death by up-regulation of anti-apoptotic gene expression. J Leukoc Biol 2003;74:135-48
78. Fais S, Malorni W. Leukocyte uropod formation and membrane/ cytoskeleton linkage in immune interactions. J Leukoc Biol 2003;73:556-63
79. Lambert C, Landau AM, Desbarats J. Fas beyond death: A regenerative role for Fas in the nervous system. Apoptosis 2003;8:551-62
80. Ugolini G, Raul C, Ferri A, et al. Fas/tumor necrosis factor receptor death is required for axotomy-induced death of motor neurons in vivo. J Neurosci 2003;23:8526-31
81. Su SH, Anderson AJ, Cripps DH, et al. Fas and Fas ligand are associated with neuritic degeneration in the AD brain and participate in beta-amyloid-induced neuronal death. Neurobiol Dis 2003;12:182-93